In a recent study published in the journal JAMA Network Open, researchers determined new-onset diabetes, hypertension, and hyperlipidemia, all cardiometabolic disorders in adult coronavirus disease 2019 (COVID-19) patients under treatment in California, United States of America (USA) between March 2020 and June 2022.

Related Keywords

California , United States , Los Angeles , Aimee Molineux , Neha Mathur , Neha Mathurfeb , Research Letter , Sinai Health System In Los Angeles , With Risk , Incident Diabetes After , Image Credit , Cedars Sinai Health System , Coronavirus Disease Covid 19 , Diabetes , Ypertension High Blood Pressure , Ardiometabolic , Coronavirus , Healthcare , Hyperlipidemia , Micron , Pandemic , Research , Cars , Ars Cov 2 ,